MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
attributable to common...
-$10,175,700
(-27.40%↓ Y/Y)
Net loss
attributable to...
-$487
(-558.11%↓ Y/Y)
Other income and
expense, net
$73,430
(325.02%↑ Y/Y)
Change in fair value of
liability classified...
$10,096
(-38.03%↓ Y/Y)
Net loss
-$10,176,187
(-27.41%↓ Y/Y)
Total other income
(expense), net
$64,759
(105.15%↑ Y/Y)
Interest expense, net
$18,767
(-98.55%↓ Y/Y)
Loss from operations
-$10,240,946
(-52.17%↓ Y/Y)
Federal grants
$5,066,650
(-2.75%↓ Y/Y)
Total operating
expenses
$15,307,596
(28.20%↑ Y/Y)
Research and development
$10,376,895
(43.74%↑ Y/Y)
General and
administrative
$4,930,701
(4.45%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Ensysce Biosciences, Inc. (ENSC)
Ensysce Biosciences, Inc. (ENSC)